CRVO、MEに対するアバスチン（Bevacizumab）
http://www.medscape.com/viewarticle/778296?nlid=27923_450&src=wnl_edit_medp_opth&spon=36
Benefit From Bevacizumab for Macular Edema in Central Retinal Vein Occlusion: Twelve-Month Results of a Prospective, Randomized Study
Ophthalmology. 2012;119:2587-2591
every 6 weeks for the first 6 months, then during the second 6 months of the study all patients received bevacizumab at 6-week intervals
まじですか、、、